
What We're Reading: Pelosi Drug Bill; Sarepta's Second Chance; Mental Health Care
Speaker Nancy Pelosi’s, D-California, drug bill passes in the House; the FDA approves Vyondys 53, from Sarepta Therapeutics, to treat Duchenne muscular dystrophy; San Francisco tackles homelessness, mental illness, and substance abuse.
Pelosi Drug Bill Approved by the House of Representatives
High drug costs are at the center of an ongoing debate in the House and Senate. However, on Thursday, the House voted 230-192 to pass Pelosi’s controversial drug pricing plan, HR 3, according to
Sarepta Therapeutics’ Duchenne Drug Approved
Also on Thursday, the FDA changed its mind, approving Vyondys 53 (golodirsen), a drug to treat Duchenne muscular dystrophy (DMD),
Mental Health Care Front-and-Center in San Francisco
A new controversial California state law,
Related to this article








